Recent Advances in the Biology and Treatment of Brain Metastases of Non-small Cell Lung Cancer: Summary of a Multidisciplinary Roundtable Discussion

Overview

Journal ESMO Open

Publisher Elsevier

Specialty Oncology

Date 2018 Feb 2

PMID 29387475

Citations 37

Authors

Matthias Preusser

Frank Winkler

Manuel Valiente

Christian Manegold

Elizabeth Moyal

Georg Widhalm

Jorg-Christian Tonn

Christoph Zielinski

Affiliations

Soon will be listed here.

Abstract

This article is the result of a round table discussion held at the European Lung Cancer Conference (ELCC) in Geneva in May 2017. Its purpose is to explore and discuss the advances in the knowledge about the biology and treatment of brain metastases originating from -small cell lung cancer. The authors propose a series of recommendations for research and treatment within the discussed context.

Citing Articles

Cancer brain metastasis: molecular mechanisms and therapeutic strategies.

Lu Y, Huang Y, Zhu C, Li Z, Zhang B, Sheng H Mol Biomed. 2025; 6(1):12.

PMID: 39998776 PMC: 11861501. DOI: 10.1186/s43556-025-00251-0.

Treatment of brain metastases from non-small cell lung cancer: preclinical, clinical, and translational research.

Sampat P, Cortese A, Goodman A, Ghelani G, Mix M, Graziano S Front Oncol. 2024; 14:1411432.

PMID: 39534096 PMC: 11554526. DOI: 10.3389/fonc.2024.1411432.

Prioritizing Radiation and Targeted Systemic Therapies in Patients with Resected Brain Metastases from Lung Cancer Primaries with Targetable Mutations: A Report from a Multi-Site Single Institution.

Wuu Y, Kokabee M, Gui B, Lee S, Stone J, Karten J Cancers (Basel). 2024; 16(19).

PMID: 39409890 PMC: 11475032. DOI: 10.3390/cancers16193270.

[Progress and Discussion of Perioperative Targeted Therapy in Patients  with EGFR-mutated Resectable Non-small Cell Lung Cancer].

Song P, Cui Y Zhongguo Fei Ai Za Zhi. 2024; 27(5):383-390.

PMID: 38880926 PMC: 11183319. DOI: 10.3779/j.issn.1009-3419.2024.106.11.

Efficacy and safety of dacomitinib in treatment-naïve patients with advanced NSCLC harboring uncommon EGFR mutation: an ambispective cohort study.

Pu X, Zhou Y, Kong Y, Chen B, Yang A, Li J BMC Cancer. 2023; 23(1):982.

PMID: 37840124 PMC: 10577935. DOI: 10.1186/s12885-023-11465-2.

References

Jonathan E, Bernhard E, McKenna W . How does radiation kill cells?. Curr Opin Chem Biol. 1999; 3(1):77-83. DOI: 10.1016/s1367-5931(99)80014-3. View

Lagerwaard F, Levendag P, Nowak P, Eijkenboom W, Hanssens P, Schmitz P . Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999; 43(4):795-803. DOI: 10.1016/s0360-3016(98)00442-8. View

Postmus P, Haaxma-Reiche H, Smit E, Groen H, Karnicka H, LEWINSKI T . Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J Clin Oncol. 2000; 18(19):3400-8. DOI: 10.1200/JCO.2000.18.19.3400. View

Fidler I, Yano S, Zhang R, Fujimaki T, Bucana C . The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol. 2002; 3(1):53-7. DOI: 10.1016/s1470-2045(01)00622-2. View

Antonadou D, Paraskevaidis M, Sarris G, Coliarakis N, Economou I, Karageorgis P . Phase II randomized trial of temozolomide and concurrent radiotherapy in patients with brain metastases. J Clin Oncol. 2002; 20(17):3644-50. DOI: 10.1200/JCO.2002.04.140. View

Mornex F, Thomas L, Mohr P, Hauschild A, Delaunay M, Lesimple T . A prospective randomized multicentre phase III trial of fotemustine plus whole brain irradiation versus fotemustine alone in cerebral metastases of malignant melanoma. Melanoma Res. 2003; 13(1):97-103. DOI: 10.1097/00008390-200302000-00016. View

Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A . Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003; 300(5622):1155-9. DOI: 10.1126/science.1082504. View

Mehta M, Rodrigus P, Terhaard C, Rao A, Suh J, Roa W . Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases. J Clin Oncol. 2003; 21(13):2529-36. DOI: 10.1200/JCO.2003.12.122. View

Fife K, Colman M, Stevens G, Firth I, Moon D, Shannon K . Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol. 2004; 22(7):1293-300. DOI: 10.1200/JCO.2004.08.140. View

10.

Barnholtz-Sloan J, Sloan A, Davis F, Vigneau F, Lai P, Sawaya R . Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol. 2004; 22(14):2865-72. DOI: 10.1200/JCO.2004.12.149. View

11.

Verger E, Gil M, Yaya R, Vinolas N, Villa S, Pujol T . Temozolomide and concomitant whole brain radiotherapy in patients with brain metastases: a phase II randomized trial. Int J Radiat Oncol Biol Phys. 2005; 61(1):185-91. DOI: 10.1016/j.ijrobp.2004.04.061. View

12.

Mamon H, Yeap B, Janne P, Reblando J, Shrager S, Jaklitsch M . High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol. 2005; 23(7):1530-7. DOI: 10.1200/JCO.2005.04.123. View

13.

Suh J, Stea B, Nabid A, Kresl J, Fortin A, Mercier J . Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases. J Clin Oncol. 2005; 24(1):106-14. DOI: 10.1200/JCO.2004.00.1768. View

14.

Palmieri D, Chambers A, Felding-Habermann B, Huang S, Steeg P . The biology of metastasis to a sanctuary site. Clin Cancer Res. 2007; 13(6):1656-62. DOI: 10.1158/1078-0432.CCR-06-2659. View

15.

Gerstner E, Fine R . Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm. J Clin Oncol. 2007; 25(16):2306-12. DOI: 10.1200/JCO.2006.10.0677. View

16.

Yoo H, Kim Y, Nam B, Shin S, Yang H, Lee J . Reduced local recurrence of a single brain metastasis through microscopic total resection. J Neurosurg. 2008; 110(4):730-6. DOI: 10.3171/2008.8.JNS08448. View

17.

Lee Y, Auh S, Wang Y, Burnette B, Wang Y, Meng Y . Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood. 2009; 114(3):589-95. PMC: 2713472. DOI: 10.1182/blood-2009-02-206870. View

18.

Bos P, Zhang X, Nadal C, Shu W, Gomis R, Nguyen D . Genes that mediate breast cancer metastasis to the brain. Nature. 2009; 459(7249):1005-9. PMC: 2698953. DOI: 10.1038/nature08021. View

19.

Carbonell W, Ansorge O, Sibson N, Muschel R . The vascular basement membrane as "soil" in brain metastasis. PLoS One. 2009; 4(6):e5857. PMC: 2689678. DOI: 10.1371/journal.pone.0005857. View

20.

Mok T, Wu Y, Thongprasert S, Yang C, Chu D, Saijo N . Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma. N Engl J Med. 2009; 361(10):947-57. DOI: 10.1056/NEJMoa0810699. View